Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Our Science Surgery series answers your cancer science questions. Read our answer to Patrick’s question.
Step inside a virtual world where our Grand Challenge scientists are hoping to redefine the way we look at cancer.
Our researchers in Glasgow might have found a way to shut down certain cancer cells’ fuel supply with a specially designed diet.
Find out how our scientists are developing a way to target a troublesome cancer molecule, LOX.
Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund.
New research predicts that 2 in 3 cancers are ‘due to bad luck’, we look at why the story is a bit more complicated than that.
We’re backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.
Our scientists are developing a new experimental drug to target how cancer cells repair their DNA, and upset cancer’s balance.